Roflumilast
BY217/M2-013
Phase 3 small_molecule completed
Quick answer
Roflumilast for Asthma is a Phase 3 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Asthma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed